Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung cancer
-
AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort
-
AstraZeneca and the University of Cambridge announce new joint PhD and clinical research scholarships
-
AstraZeneca to collaborate with Inserm in Type 2 Diabetes and Chronic Kidney Disease studies
-
AstraZeneca to collaborate with the University of Michigan to advance treatments for Chronic Kidney Disease
-
AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT
-
AstraZeneca reveals findings of archaeological dig as build gets underway at Cambridge Biomedical Campus
-
New real-world data analysis finds no evidence of increased risk of hospitalisation for heart failure with saxagliptin compared with sitagliptin
-
AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin, saxagliptin and metformin for the treatment of type 2 diabetes
-
AstraZeneca to present data demonstrating progress of its comprehensive diabetes portfolio at the American Diabetes Association 75th Scientific Sessions
Latest articles and press releases
All of our latest press releases and articles are available to explore
